Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Intercalating and Maintenance Gefitinib in Combination With Chemotherapy for Advanced EGFR-mutant NSCLC
ClinicalTrials.gov study NCT02299765. IPD Sharing: Not stated. Countries: 1. Publications: 15.
D-0316 Versus Icotinib in Patients With Locally Advanced or Metastatic EGFR Sensitising Mutation Positive NSCLC
ClinicalTrials.gov study NCT04206072. IPD Sharing: Not stated. Countries: 1. Publications: 2.
CTLA-4 and PD-1 Antibodies Expressing EGFR-CAR-T Cells for EGFR Positive Advanced Solid Tumor
ClinicalTrials.gov study NCT03182816. IPD Sharing: NO. Countries: 1. Publications: 1.
Gefitinib in Combination With Anlotinib or Placebo in Previously Untreated EGFR-mutant NSCLC
ClinicalTrials.gov study NCT04028778. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Study of ASP8273 in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-Naïve Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations
ClinicalTrials.gov study NCT02500927. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 in High Grade Gliomas
ClinicalTrials.gov study NCT00589706. IPD Sharing: NO. Countries: 1. Publications: 1.
MEchanisms of Resistance in EGFR Mutated Nonpretreated Advanced Lung Cancer Receiving OSimErtib
ClinicalTrials.gov study NCT03865511. IPD Sharing: NO. Countries: 1. Publications: 1.
Gefitinib or Docetaxel as Second Line Therapy for Wild-type Epidermal Growth Factor Receptor (EGFR) NSCLC
ClinicalTrials.gov study NCT01755923. IPD Sharing: Not stated. Countries: 1. Publications: 10.
Concurrent EGFR-TKIs and Thoracic Radiation Therapy in Active EGFR Mutation for 1st Line Treatment of Stage IV NSCLC
ClinicalTrials.gov study NCT02353741. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Intravenous EEDVsMit in Children With Recurrent / Refractory Solid or CNS Tumours Expressing EGFR
ClinicalTrials.gov study NCT02687386. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Assessing an Oral EGFR Inhibitor,YK-209A in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR
ClinicalTrials.gov study NCT05767866. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase III Study of SKB264 for EGFR Mutant NSCLC Patients
ClinicalTrials.gov study NCT05870319. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid Tumors
ClinicalTrials.gov study NCT06358677. IPD Sharing: NO. Countries: 1. Publications: 20.
Treatment of Chemotherapy Refractory EGFR(Epidermal Growth Factor Receptor) Positive Advanced Solid Tumors (CART-EGFR)
ClinicalTrials.gov study NCT01869166. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Pilot Trial of EGF Ointment for the Patients With EGFR-i Related Skin Side Effects
ClinicalTrials.gov study NCT02284139. IPD Sharing: Not stated. Countries: 1. Publications: 1.
D-0316 in Patients With EGFR Positive Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT03861156. IPD Sharing: NO. Countries: 1. Publications: 1.
Almonertinib Combined With Cerebral Radiation Treat Brain Metastases From EGFR Positive NSCLC
ClinicalTrials.gov study NCT04905550. IPD Sharing: NO. Countries: 1. Publications: 11.
The HER Project: HRD in EGFR-mutated NSCLC
ClinicalTrials.gov study NCT07303218. IPD Sharing: Not stated. Countries: 1. Publications: 22.
IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain Metastases
ClinicalTrials.gov study NCT02556593. IPD Sharing: Not stated. Countries: 1. Publications: 34.
Safety, Pharmacokinetic and Preliminary Efficacy Study of AC0010 in Patients With EGFR T790M Positive NSCLC
ClinicalTrials.gov study NCT02330367. IPD Sharing: NO. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.